Given the frequent discordance between LDL-C concentrations and atherogenic particle burden in MetS and T2DM, measurement of apoB or non-HDL cholesterol offers a more accurate estimation of cardiovascular risk. This evidence concerns the gene APOB and type 2 diabetes mellitus.